| The significance of vasoactive intestinal peptide in immunomodulation M Delgado, D Pozo, D Ganea Pharmacological reviews 56 (2), 249-290, 2004 | 538 | 2004 |
| Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin D Pozo, RJ Reiter, JR Calvo, JM Guerrero Journal of cellular biochemistry 65 (3), 430-442, 1997 | 380 | 1997 |
| Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide‐induced multiple organ dysfunction syndrome in rats E Crespo, M Macías, D Pozo, G Escames, M Martín, F Vives, JM Guerrero, ... The FASEB Journal 13 (12), 1537-1546, 1999 | 369 | 1999 |
| Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum D Pozo, RJ Reiter, JR Calvo, JM Guerrero Life sciences 55 (24), PL455-PL460, 1994 | 351 | 1994 |
| The modulatory role of melatonin on immune responsiveness A Carrillo-Vico, RJ Reiter, PJ Lardone, JL Herrera, ... Current opinion in investigational drugs 7 (5), 423, 2006 | 337 | 2006 |
| Melatonin reduces nitric oxide synthase activity in rat hypothalamus I Bettahi, D Pozo, C Osuna, RJ Reiter, D Acuña‐Castroviejo, JM Guerrero Journal of pineal research 20 (4), 205-210, 1996 | 294 | 1996 |
| Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines S García‐Mauriño, D Pozo, JR Calvo, JM Guerrero Journal of pineal research 29 (3), 129-137, 2000 | 242 | 2000 |
| Melatonin activates Th1 lymphocytes by increasing IL-12 production S García-Mauriño, D Pozo, A Carrillo-Vico, JR Calvo, JM Guerrero Life sciences 65 (20), 2143-2150, 1999 | 242 | 1999 |
| Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6 M Delgado, C Martinez, D Pozo, JR Calvo, J Leceta, D Ganea, ... The Journal of Immunology 162 (2), 1200-1205, 1999 | 235 | 1999 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies M Delgado, D Pozo, C Martinez, J Leceta, JR Calvo, D Ganea, ... The Journal of Immunology 162 (4), 2358-2367, 1999 | 210 | 1999 |
| Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells JR Calvo, M Rafii‐EI‐ldrissi, D Pozo, JM Guerrero Journal of pineal research 18 (3), 119-126, 1995 | 210 | 1995 |
| Expression of the Mel1a‐melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen D Pozo, M Delgado, JM Fernandez‐Santos, JR Calvo, RP Gomariz, ... The FASEB journal 11 (6), 466-473, 1997 | 208 | 1997 |
| Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders A Chorny, E Gonzalez-Rey, A Fernandez-Martin, D Pozo, D Ganea, ... Proceedings of the National Academy of Sciences 102 (38), 13562-13567, 2005 | 207 | 2005 |
| Melatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro MM Leon‐Blanco, JM Guerrero, RJ Reiter, JR Calvo, D Pozo Journal of pineal research 35 (3), 204-211, 2003 | 203 | 2003 |
| Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2 A Yeste, MC Takenaka, ID Mascanfroni, M Nadeau, JE Kenison, B Patel, ... Science signaling 9 (433), ra61-ra61, 2016 | 202 | 2016 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages C Martínez, M Delgado, D Pozo, J Leceta, JR Calvo, D Ganea, ... Journal of leukocyte biology 63 (5), 591-601, 1998 | 182 | 1998 |
| Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies R Klippstein, D Pozo Nanomedicine: Nanotechnology, Biology and Medicine 6 (4), 523-529, 2010 | 181 | 2010 |
| mRNA expression of nuclear receptor RZR/RORα, melatonin membrane receptor MT1, and hydroxindole‐O‐methyltransferase in different populations of human … D Pozo, S García‐Mauriño, JM Guerrero, JR Calvo Journal of pineal research 37 (1), 48-54, 2004 | 157 | 2004 |
| Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety … O Fernández, G Izquierdo, V Fernández, L Leyva, V Reyes, M Guerrero, ... PloS one 13 (5), e0195891, 2018 | 154 | 2018 |
| Immunobiology of vasoactive intestinal peptide (VIP) D Pozo, M Delgado, C Martı́nez, JM Guerrero, J Leceta, RP Gomariz, ... Immunology today 21 (1), 7-11, 2000 | 142 | 2000 |
